Insider trades
Priya Singhal, Executive of Biogen BIIB, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $665.7K. The latest trade was on 02/13.
Priya Singhal
Head of Development
- Company
- Biogen BIIB
- First filing
- 23/01/27
- Trades
- 83 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$665.7K
- Last trade
- 02/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BiogenBIIB | Open-market sale10b5-1 plan | 02/09 | 02/10 | 2,660 sh | $199.83 | $531,547.8 | −24.9% |
BiogenBIIB | Open-market sale10b5-1 plan | 02/02 | 02/03 | 748 sh | $179.30 | $134,116.4 | −10.7% |
BiogenBIIB | Open-market sale10b5-1 plan | 25/09/02 | 25/09/02 | 517 sh | $133.55 | $69,045.35 | −8.2% |
BiogenBIIB | Open-market sale10b5-1 plan | 25/05/19 | 25/05/20 | 3,806 sh | $126.25 | $480,507.5 | −41.2% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/12/09 | 24/12/09 | 110 sh | $157.21 | $17,293.1 | −2.0% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/09/03 | 24/09/05 | 431 sh | $204.22 | $88,018.82 | −7.5% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/04/02 | 24/04/03 | 93 sh | $213.09 | $19,817.37 | −1.9% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/02/22 | 24/02/26 | 262 sh | $221.23 | $57,962.26 | −5.1% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/02/16 | 24/02/21 | 108 sh | $221.49 | $23,920.92 | −2.1% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/02/12 | 24/02/13 | 419 sh | $239.45 | $100,329.55 | −8.5% |
BiogenBIIB | Open-market sale10b5-1 plan | 24/02/02 | 24/02/05 | 634 sh | $245.93 | $155,919.62 | −13.4% |
BiogenBIIB | Open-market sale10b5-1 plan | 23/12/11 | 23/12/12 | 110 sh | $248.00 | $27,280 | −3.1% |
BiogenBIIB | Open-market sale10b5-1 plan | 23/09/05 | 23/09/06 | 431 sh | $269.43 | $116,124.33 | −11.4% |
BiogenBIIB | Open-market sale10b5-1 plan | 23/07/03 | 23/07/05 | 81 sh | $282.87 | $22,912.47 | −2.7% |
BiogenBIIB | Open-market sale10b5-1 plan | 23/04/04 | 23/04/06 | 91 sh | $277.11 | $25,217.01 | −3.1% |
BiogenBIIB | Open-market sale | 23/03/28 | 23/03/30 | 568 sh | $270.06 | $153,394.08 | −16.7% |